First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites
Open Access
- 17 August 2010
- journal article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 15 (10) , 1198-1203
Abstract
Objective The development of a biomarker of exposure based on the evaluation of the human antibody response specific to Anopheles salivary proteins seems promising in improving malaria control. The IgG response specific to the gSG6-P1 peptide has already been validated as a biomarker of An. gambiae exposure. This study represents a first attempt to validate the gSG6-P1 peptide as an epidemiological tool evaluating exposure to An. funestus bites, the second main malaria vector in sub-Saharan Africa. Methods A multi-disciplinary survey was performed in a Senegalese village where An. funestus represents the principal anopheline species. The IgG antibody level specific to gSG6-P1 was evaluated and compared in the same children before, at the peak and after the rainy season. Results Two-thirds of the children developed a specific IgG response to gSG6-P1 during the study period and – more interestingly – before the rainy season, when An. funestus was the only anopheline species reported. The specific IgG response increased during the An. funestus exposure season, and a positive association between the IgG level and the level of exposure to An. funestus bites was observed. Conclusions The results suggest that the evaluation of the IgG response specific to gSG6-P1 in children could also represent a biomarker of exposure to An. funestus bites. The availability of such a biomarker evaluating the exposure to both main Plasmodium falciparum vectors in Africa could be particularly relevant as a direct criterion for the evaluation of the efficacy of vector control strategies.Keywords
This publication has 15 references indexed in Scilit:
- Human Antibody Response to Anopheles gambiae Saliva: An Immuno-Epidemiological Biomarker to Evaluate the Efficacy of Insecticide-Treated Nets in Malaria Vector ControlThe American Journal of Tropical Medicine and Hygiene, 2010
- Developing Global Maps of the Dominant Anopheles Vectors of Human MalariaPLOS Medicine, 2010
- Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bitesMalaria Journal, 2009
- Novel Peptide Marker Corresponding to Salivary Protein gSG6 Potentially Identifies Exposure to Anopheles BitesPLOS ONE, 2008
- Human IgG Antibody Response to Glossina Saliva: An Epidemiologic Marker of Exposure to Glossina BitesThe American Journal of Tropical Medicine and Hygiene, 2008
- Bionomics of malaria vectors and relationship with malaria transmission and epidemiology in three physiographic zones in the Senegal River BasinActa Tropica, 2007
- Immune interactions between mosquitoes and their hostsParasite Immunology, 2006
- Advances in the study of Anopheles funestus, a major vector of malaria in AfricaInsect Biochemistry and Molecular Biology, 2004
- Human IgG1 and IgG4: the main antibodies against Triatoma infestans (Hemiptera: Reduviidae) salivary gland proteins.The American Journal of Tropical Medicine and Hygiene, 2001
- Comeback of Anopheles funestus in Sahelian SenegalThe Lancet, 2001